Gastro-oesophageal Reflux Disease Trial, Recruiting NCT04930029 Sponsor: University Hospital, Lille Condition: Gastro-oesophageal Reflux Disease
Back to Gord

Gastro-oesophageal Reflux Disease Trial, Recruiting

NCT04930029
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who had a specific type of weight-loss surgery called OAGB (a form of gastric bypass) 10 years ago, roughly between 2009 and 2013, where a particular section of the intestine (either 150cm or 200cm) was used during the procedure
  • People who met the standard medical guidelines for weight-loss surgery at the time they had their operation, as set out by the French health authority (HAS, 2009), and had the surgery performed at a specialist centre
  • People who agree to have a camera examination of the digestive tract (an endoscopy) with small tissue samples (biopsies) taken as part of this 10-year follow-up
  • People who have given their informed consent to take part in the trial
  • People who have health insurance coverage

Who may not be able to join:

  • People who, at the time of their original surgery, had medical reasons that made weight-loss surgery unsuitable, as defined by the French health authority (HAS, 2009)
  • People who are in prison, or who are under legal guardianship or a court-appointed protective arrangement
  • People who are already taking part in another research study that may conflict with this trial (called OMEGA10)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert CAIAZZO, MD,PhD, University Hospital, Lille

Phone: 0320445962

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
15 September 2021
Est. completion
1 July 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Incidence of serious surgery-related adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov